227 related articles for article (PubMed ID: 8504962)
1. p53 expression and K-ras mutation in colorectal adenomas.
Scott N; Bell SM; Sagar P; Blair GE; Dixon MF; Quirke P
Gut; 1993 May; 34(5):621-4. PubMed ID: 8504962
[TBL] [Abstract][Full Text] [Related]
2. High frequency of K-ras mutations in human colorectal hyperplastic polyps.
Otori K; Oda Y; Sugiyama K; Hasebe T; Mukai K; Fujii T; Tajiri H; Yoshida S; Fukushima S; Esumi H
Gut; 1997 May; 40(5):660-3. PubMed ID: 9203947
[TBL] [Abstract][Full Text] [Related]
3. Analysis of K-ras codon 12 mutations and p53 overexpression in colorectal nodule-aggregating tumors.
Kusaka T; Fukui H; Sano Y; Ueda Y; Chiba T; Fujimori T
J Gastroenterol Hepatol; 2000 Oct; 15(10):1151-7. PubMed ID: 11106095
[TBL] [Abstract][Full Text] [Related]
4. CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation.
Kim H; Yang XL; Rosada C; Hamilton SR; August JT
Arch Biochem Biophys; 1994 May; 310(2):504-7. PubMed ID: 7513984
[TBL] [Abstract][Full Text] [Related]
5. Genetic events in sporadic colorectal adenomas: K-ras and p53 heterozygous mutations are not sufficient for malignant progression.
De Benedetti L; Varesco L; Pellegata NS; Losi L; Gismondi V; Casarino L; Sciallero S; Bonelli L; Biticchi R; Bafico A
Anticancer Res; 1993; 13(3):667-70. PubMed ID: 8317895
[TBL] [Abstract][Full Text] [Related]
6. Genetic epidemiology of mutated K-ras proto-oncogene, altered suppressor genes, and microsatellite instability in colorectal adenomas.
Rashid A; Zahurak M; Goodman SN; Hamilton SR
Gut; 1999 Jun; 44(6):826-33. PubMed ID: 10323885
[TBL] [Abstract][Full Text] [Related]
7. [A study on the mutation of P53 and K-ras gene in colorectal adenomas and colorectal carcinomas].
Xu W; Cheng Y; Shen XF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 43(6):821-6. PubMed ID: 23387205
[TBL] [Abstract][Full Text] [Related]
8. Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics.
Einspahr JG; Martinez ME; Jiang R; Hsu CH; Rashid A; Bhattacharrya AK; Ahnen DJ; Jacobs ET; Houlihan PS; Webb CR; Alberts DS; Hamilton SR
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1443-50. PubMed ID: 16896030
[TBL] [Abstract][Full Text] [Related]
9. Detection of genetic alterations in the p53 suppressor gene and the K-ras oncogene among different grades of dysplasia in patients with colorectal adenomas.
Hosaka S; Aoki Y; Akamatsu T; Nakamura N; Hosaka N; Kiyosawa K
Cancer; 2002 Jan; 94(1):219-27. PubMed ID: 11815980
[TBL] [Abstract][Full Text] [Related]
10. Molecular events including p53 and k-ras alterations in the in vitro progression of a human colorectal adenoma cell line to an adenocarcinoma.
Williams AC; Browne SJ; Yeudal WA; Paterson IC; Marshall CJ; Lane DP; Paraskeva C
Oncogene; 1993 Nov; 8(11):3063-72. PubMed ID: 8414507
[TBL] [Abstract][Full Text] [Related]
11. p53 and K-ras status in duodenal adenomas in familial adenomatous polyposis.
Kashiwagi H; Spigelman AD; Talbot IC; Debinski HS; McKie AB; Lemoine NR; Phillips RK
Br J Surg; 1997 Jun; 84(6):826-9. PubMed ID: 9189100
[TBL] [Abstract][Full Text] [Related]
12. Molecular characteristics of serrated adenomas of the colorectum.
Sawyer EJ; Cerar A; Hanby AM; Gorman P; Arends M; Talbot IC; Tomlinson IP
Gut; 2002 Aug; 51(2):200-6. PubMed ID: 12117880
[TBL] [Abstract][Full Text] [Related]
13. Frequent p53 mutation in brain (fetal)-type glycogen phosphorylase positive foci adjacent to human 'de novo' colorectal carcinomas.
Shimada S; Shiomori K; Tashima S; Tsuruta J; Ogawa M
Br J Cancer; 2001 Jun; 84(11):1497-504. PubMed ID: 11384100
[TBL] [Abstract][Full Text] [Related]
14. K-ras and p53 mutations in colonic lavage fluid of patients with colorectal neoplasias.
Heinzlmann M; Neynaber S; Heldwein W; Folwaczny C
Digestion; 2001; 63(4):229-33. PubMed ID: 11435722
[TBL] [Abstract][Full Text] [Related]
15. Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not in adenocarcinomas.
Shibata D; Schaeffer J; Li ZH; Capella G; Perucho M
J Natl Cancer Inst; 1993 Jul; 85(13):1058-63. PubMed ID: 8515492
[TBL] [Abstract][Full Text] [Related]
16. Intratumor heterogeneity of k-ras and p53 mutations among human colorectal adenomas containing early cancer.
Giaretti W; Rapallo A; Sciutto A; Macciocu B; Geido E; Hermsen MA; Postma C; Baak JP; Williams RA; Meijer GA
Anal Cell Pathol; 2000; 21(2):49-57. PubMed ID: 11310641
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
[TBL] [Abstract][Full Text] [Related]
18. Relationship between cyclooxygenase-2 expression and K-ras gene mutation in colorectal adenomas.
Fujita M; Fukui H; Kusaka T; Morita K; Fujii S; Ueda Y; Chiba T; Sakamoto C; Kawamata H; Fujimori T
J Gastroenterol Hepatol; 2000 Nov; 15(11):1277-81. PubMed ID: 11129221
[TBL] [Abstract][Full Text] [Related]
19. K-ras mutations and HLA-DR expression in large bowel adenomas.
Norheim Andersen S; Breivik J; Løvig T; Meling GI; Gaudernack G; Clausen OP; Schjölberg A; Fausa O; Langmark F; Lund E; Rognum TO
Br J Cancer; 1996 Jul; 74(1):99-108. PubMed ID: 8679466
[TBL] [Abstract][Full Text] [Related]
20. Frequent p53 gene mutations in serrated adenomas of the colorectum.
Hiyama T; Yokozaki H; Shimamoto F; Haruma K; Yasui W; Kajiyama G; Tahara E
J Pathol; 1998 Oct; 186(2):131-9. PubMed ID: 9924427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
